Reply: To PMID 23099497

Affiliations

¹ *Ophthalmology Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain †VISSUM, Alicante Institute of Ophthalmology, Alicante, Spain ‡Ophthalmology Unit, Albacete Medical School, Castilla La Mancha University, Albacete, Spain §Allergy Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain.

Comment

Javier A Montero et al. Retina. 2013 Nov-Dec.

. 2013 Nov-Dec;33(10):2185-6.

doi: 10.1097/IAE.0b013e31829f7334.

¹ *Ophthalmology Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain †VISSUM, Alicante Institute of Ophthalmology, Alicante, Spain ‡Ophthalmology Unit, Albacete Medical School, Castilla La Mancha University, Albacete, Spain §Allergy Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain.

No abstract available

Comment on

Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab.
Montero JA, Ruiz-Moreno JM, Sanchis-Merino E, Perez-Martin S. Montero JA, et al. Retina. 2013 Mar;33(3):508-12. doi: 10.1097/IAE.0b013e3182695ba0. Retina. 2013. PMID: 23099497
Correspondence.
Davis A, Cohen SM, Pautler SE, Billiris-Findlay K, Eichenbaum DA. Davis A, et al. Retina. 2013 Nov-Dec;33(10):2185. doi: 10.1097/IAE.0b013e31829f731e. Retina. 2013. PMID: 23903791 No abstract available.